Quest Diagnostics Inc (Quest Diagnostics) is a provider of diagnostic information services to patients and physicians through a network of laboratories and company-owned patient service centers. It offers a range of services including clinical testing with gene-based and other esoteric tests, anatomic pathology services, clinical trial testing, life insurer services and various healthcare information technology and diagnostic products. Quest Diagnostics provides its services to managed care organizations and other health insurance providers, clinicians, hospitals, retail healthcare providers, laboratories, and governmental agencies, among others. The company, along with its subsidiaries and branches, operates in North America, Asia Pacific, South America, and Europe. Quest Diagnostics is headquartered in Secaucus, New Jersey, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Quest Diagnostics Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Quest Diagnostics Inc Company Overview
- Quest Diagnostics Inc Company Snapshot
- Quest Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
- Quest Diagnostics Inc - Pipeline Analysis Overview
- Business Description
- Quest Diagnostics Inc - Key Facts
- Quest Diagnostics Inc - Major Products and Services
- Quest Diagnostics Inc Pipeline Products by Development Stage
- Quest Diagnostics Inc Ongoing Clinical Trials by Trial Status
- Quest Diagnostics Inc Pipeline Products Overview
- AAVrh74 ELISA Companion Diagnostic Assay - Duchenne Muscular Dystrophy (DMD)
- AAVrh74 ELISA Companion Diagnostic Assay - Duchenne Muscular Dystrophy (DMD) Product Overview
- AAVrh74 ELISA Companion Diagnostic Assay - Limb Girdle Muscular Dystrophy (LGMD)
- AAVrh74 ELISA Companion Diagnostic Assay - Limb Girdle Muscular Dystrophy (LGMD) Product Overview
- AI-Enabled Computational Pathology - Solid Tumor
- AI-Enabled Computational Pathology - Solid Tumor Product Overview
- Biomarker Test - Genetic Disorders
- Biomarker Test - Genetic Disorders Product Overview
- Bromotyrosine Test
- Bromotyrosine Test Product Overview
- Cardio IQ KIF6 Genotype Test
- Cardio IQ KIF6 Genotype Test Product Overview
- Cardiovascular Mortality Prediction Test
- Cardiovascular Mortality Prediction Test Product Overview
- Diagnostic Assay - Colorectal Cancer
- Diagnostic Assay - Colorectal Cancer Product Overview
- Diagnostic Test - Influenza A H5 Virus
- Diagnostic Test - Influenza A H5 Virus Product Overview
- Genotyping Assay - Cystic Fibrosis
- Genotyping Assay - Cystic Fibrosis Product Overview
- Genotyping Assay - Fragile X Syndrome
- Genotyping Assay - Fragile X Syndrome Product Overview
- HDL Function Test
- HDL Function Test Product Overview
- LungDx
- LungDx Product Overview
- MRD Test - Breast Cancer
- MRD Test - Breast Cancer Product Overview
- MRD Test - Colorectal Cancer
- MRD Test - Colorectal Cancer Product Overview
- MRD Test - Colorectal Cancer Clinical Trial
- MRD Test - Lung Cancer
- MRD Test - Lung Cancer Product Overview
- Multi-cancer Stratification (MCaST) Blood Test
- Multi-cancer Stratification (MCaST) Blood Test Product Overview
- Oropouche Virus Test
- Oropouche Virus Test Product Overview
- Urine Biomarker Test - Prostate Cancer
- Urine Biomarker Test - Prostate Cancer Product Overview
- VeraMarker BCR Test - LDT
- VeraMarker BCR Test - LDT Product Overview
- ViroSeq HCV Assay
- ViroSeq HCV Assay Product Overview
- Quest Diagnostics Inc - Key Competitors
- Quest Diagnostics Inc - Key Employees
- Quest Diagnostics Inc - Key Employee Biographies
- Quest Diagnostics Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Joint Venture
- Recent Developments
- Quest Diagnostics Inc, Recent Developments
- Jun 10, 2025: Quest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology
- Jun 10, 2025: Quest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology
- Jun 04, 2025: LifeLabs Introduces Three Blood-Based Alzheimer’s Disease Tests, Including Support Services
- May 13, 2025: Oncologists Report Seeing More Advanced Cancers and Say Current Tests Are Not Catching Cancer Recurrence Early Enough, New Quest Diagnostics Report Finds
- Apr 22, 2025: Quest Diagnostics Announces Results for Q1 Ended March 31, 2025
- Apr 10, 2025: Quest introduces blood test to confirm amyloid brain pathology in Alzheimer's
- Apr 02, 2025: Quest Diagnostics Introduces HPV Specimen Self-Collection for Cervical Cancer Screening
- Mar 19, 2025: Quest Diagnostics To Highlight Strategic Priorities To Drive Sustainable Growth and Deliver Long-Term Shareholder Value at 2025 Investor Day
- Dec 11, 2024: Quest Diagnostics Strengthens Supply Chain Management With Enhanced ESG Risk Assessment, Supplier Diversity, and Commitment to Ethical Standards
- Dec 04, 2024: Quest Diagnostics Fortifies Patient Data Privacy and Cybersecurity With Robust Safeguards and Ongoing Threat Mitigation Strategies
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Quest Diagnostics Inc Pipeline Products and Ongoing Clinical Trials Overview
- Quest Diagnostics Inc Pipeline Products by Equipment Type
- Quest Diagnostics Inc Pipeline Products by Indication
- Quest Diagnostics Inc Ongoing Clinical Trials by Trial Status
- Quest Diagnostics Inc, Key Facts
- Quest Diagnostics Inc, Major Products and Services
- Quest Diagnostics Inc Number of Pipeline Products by Development Stage
- Quest Diagnostics Inc Pipeline Products Summary by Development Stage
- Quest Diagnostics Inc Ongoing Clinical Trials by Trial Status
- Quest Diagnostics Inc Ongoing Clinical Trials Summary
- AAVrh74 ELISA Companion Diagnostic Assay - Duchenne Muscular Dystrophy (DMD) - Product Status
- AAVrh74 ELISA Companion Diagnostic Assay - Duchenne Muscular Dystrophy (DMD) - Product Description
- AAVrh74 ELISA Companion Diagnostic Assay - Limb Girdle Muscular Dystrophy (LGMD) - Product Status
- AAVrh74 ELISA Companion Diagnostic Assay - Limb Girdle Muscular Dystrophy (LGMD) - Product Description
- AI-Enabled Computational Pathology - Solid Tumor - Product Status
- AI-Enabled Computational Pathology - Solid Tumor - Product Description
- Biomarker Test - Genetic Disorders - Product Status
- Biomarker Test - Genetic Disorders - Product Description
- Bromotyrosine Test - Product Status
- Bromotyrosine Test - Product Description
- Cardio IQ KIF6 Genotype Test - Product Status
- Cardio IQ KIF6 Genotype Test - Product Description
- Cardiovascular Mortality Prediction Test - Product Status
- Cardiovascular Mortality Prediction Test - Product Description
- Diagnostic Assay - Colorectal Cancer - Product Status
- Diagnostic Assay - Colorectal Cancer - Product Description
- Diagnostic Test - Influenza A H5 Virus - Product Status
- Diagnostic Test - Influenza A H5 Virus - Product Description
- Genotyping Assay - Cystic Fibrosis - Product Status
- Genotyping Assay - Cystic Fibrosis - Product Description
- Genotyping Assay - Fragile X Syndrome - Product Status
- Genotyping Assay - Fragile X Syndrome - Product Description
- HDL Function Test - Product Status
- HDL Function Test - Product Description
- LungDx - Product Status
- LungDx - Product Description
- MRD Test - Breast Cancer - Product Status
- MRD Test - Breast Cancer - Product Description
- MRD Test - Colorectal Cancer - Product Status
- MRD Test - Colorectal Cancer - Product Description
- MRD Test - Colorectal Cancer - A Prospective Observational Cohort Study for Early Detection of Treatment Failure in Metastatic Colorectal Cancer Patients Undergoing Systemic Chemotherapy and Liver Resection with Curative Intent
- MRD Test - Lung Cancer - Product Status
- MRD Test - Lung Cancer - Product Description
- Multi-cancer Stratification (MCaST) Blood Test - Product Status
- Multi-cancer Stratification (MCaST) Blood Test - Product Description
- Oropouche Virus Test - Product Status
- Oropouche Virus Test - Product Description
- Urine Biomarker Test - Prostate Cancer - Product Status
- Urine Biomarker Test - Prostate Cancer - Product Description
- VeraMarker BCR Test - LDT - Product Status
- VeraMarker BCR Test - LDT - Product Description
- ViroSeq HCV Assay - Product Status
- ViroSeq HCV Assay - Product Description
- Quest Diagnostics Inc, Key Employees
- Quest Diagnostics Inc, Key Employee Biographies
- Quest Diagnostics Inc, Subsidiaries
- Quest Diagnostics Inc, Joint Venture
- Glossary
- Quest Diagnostics Inc Pipeline Products by Equipment Type
- Quest Diagnostics Inc Pipeline Products by Development Stage
- Quest Diagnostics Inc Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Nymox Pharmaceutical Corp
- Novant Health Inc
- Psychemedics Corp
- RadNet Inc
- Net Medical Xpress Solutions Inc
- Laboratory Corp of America Holdings
- Bio-Rad Laboratories Inc
- Thermo Fisher Scientific Inc
- Celcuity Inc
- Life Technologies Corp
- Alere Inc
- Personalis Inc
- OpGen Inc
